The DOI matches its Crossref record; 97 of the 99 references it cites were found in a registry or an index.
The Role of the Inflammasome in Neurodegenerative Diseases
Open accessAbstract
Neurodegenerative diseases are chronic, progressive disorders that occur in the central nervous system (CNS). They are characterized by the loss of neuronal structure and function and are associated with inflammation. Inflammation of the CNS is called neuroinflammation, which has been implicated in most neurodegenerative diseases, including Alzheimer’s disease (AD), Parkinson’s disease (PD), amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS). Much evidence indicates that these different conditions share a common inflammatory mechanism: the activation of the inflammasome complex in peripheral monocytes and in microglia, with the consequent production of high quantities of the pro-inflammatory cytokines IL-1β and IL-18. Inflammasomes are a group of multimeric signaling complexes that include a sensor Nod-like receptor (NLR) molecule, the adaptor protein ASC, and caspase-1. The NLRP3 inflammasome is currently the best-characterized inflammasome. Multiple signals, which are potentially provided in combination and include endogenous danger signals and pathogens, trigger the formation of an active inflammasome, which, in turn, will stimulate the cleavage and the release of bioactive cytokines including IL-1β and IL-18. In this review, we will summarize results implicating the inflammasome as a pivotal player in the pathogenesis of neurodegenerative diseases and discuss how compounds that hamper the activation of the NLRP3 inflammasome could offer novel therapeutic avenues for these diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Moreover, caspase-1 also induces pyroptosis, which is characterized by gasdermin D (GSDMD) mediated plasma membrane rupture.347”
From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [347]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammasomes: mechanism of assembly, regulation and signalling
Broz, P., & Dixit, V. M. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.58 · Cited by 3,500
NLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 mice
Heneka, M. T., Kummer, M. P., Stutz, A., Delekate, A., Schwartz, S., Vieira-Saecker, A., Griep, A., Axt, D., Remus, A., Tzeng, T.-C., et al. (2013) · Nature · doi:10.1038/nature11729 · Cited by 2,898
A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
Coll, R. C., Robertson, A. A. B., Chae, J. J., Higgins, S. C., Muñoz-Planillo, R., Inserra, M. C., Vetter, I., Dungan, L. S., Monks, B. G., Stutz, A., et al. (2015) · Nature Medicine · doi:10.1038/nm.3806 · Cited by 2,849
Mechanisms and Functions of Inflammasomes
Lamkanfi, M., & Dixit, V. M. (2014) · Cell · doi:10.1016/j.cell.2014.04.007 · Cited by 2,503
The NALP3 inflammasome is involved in the innate immune response to amyloid-β
Halle, A., Hornung, V., Petzold, G. C., Stewart, C. R., Monks, B. G., Reinheckel, T., Fitzgerald, K. A., Latz, E., Moore, K. J., & Golenbock, D. T. (2008) · Nature Immunology · doi:10.1038/ni.1636 · Cited by 2,441
Inflammasomes in health and disease
Strowig, T., Henao-Mejia, J., Elinav, E., & Flavell, R. (2012) · Nature · doi:10.1038/nature10759 · Cited by 2,230
The ketone metabolite β-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease
Youm, Y.-H., Nguyen, K. Y., Grant, R. W., Goldberg, E. L., Bodogai, M., Kim, D., D'Agostino, D., Planavsky, N., Lupfer, C., Kanneganti, T. D., et al. (2015) · Nature Medicine · doi:10.1038/nm.3804 · Cited by 2,172
Cattaneo, A., Cattane, N., Galluzzi, S., Provasi, S., Lopizzo, N., Festari, C., Ferrari, C., Guerra, U. P., Paghera, B., Muscio, C., et al. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.08.019 · Cited by 1,382
Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases
Soto, C., & Pritzkow, S. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0235-9 · Cited by 1,180
Dopamine controls systemic inflammation through inhibition of NLRP3 inflammasome
Yan, Y., Jiang, W., Liu, L., Wang, X., Ding, C., Tian, Z., & Zhou, R. (2015) · Cell · doi:10.1016/j.cell.2014.11.047 · Cited by 1,014
Cited by
Items 101–154 of 154
Hansen, N., Rentzsch, K., Hirschel, S., Bartels, C., Wiltfang, J., & Malchow, B. (2023) · Antibodies · doi:10.3390/antib12020034 · Cited by 3
“In dementia with autoantibodies, monocytes might play an important role in CNS inflammation, as highlighted in a recent review [27] on the inflammasome in neurodegenerative disorders.”
BackgroundCorrelation Analysis between Serum NLRP1 Inflammasome and Depression in Acute Stage of Stroke
Li, S., Geng, K., Yang, L., Zhang, Y., Tao, X., Cai, J., Li, L., Luo, Z., Mahato, B., Liu, Y., et al. (2025) · NeuroImmunoModulation · doi:10.1159/000546439 · Cited by 5
Hemizygous Granzyme A Mice Expressing the hSOD1G93A Transgene Show Slightly Extended Lifespan
Moreno‐Martínez, L., Santiago, L., de la Torre, M., Calvo, A. C., Pardo, J., & Osta, R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113554 · Cited by 5
Thau‐Habermann, N., Gschwendtberger, T., Bodemer, C., & Petri, S. (2025) · PLoS ONE · doi:10.1371/journal.pone.0319866 · Cited by 4
Zhang, Y., Wu, Y., Zhang, X., Guo, S., He, J., Hu, N., Huang, Y., Kong, Y., Li, Q., Sui, A., et al. (2025) · British Journal of Pharmacology · doi:10.1111/bph.70124 · Cited by 2
“Augmented neuroinflammation is a crucial pathological feature in the pathogenesis of AD (Piancone et al., 2021).”
Starr, A., Rathore, S., Daniali, M., Gaskill, P. J., Akay, C., & Jordan‐Sciutto, K. L. (2025) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-025-10254-x · Cited by 4
“…in a number of other neurologic disorders, including Alzheimer’s disease, Parkinson’s disease, amyo - trophic lateral sclerosis, traumatic brain injury, and stroke as well (Feng et al., 2020; Guan & Han, 2020; Lu et al., 2022 ; O’Brien et al., 2020; Piancone et al., 2021; Voet et al., 2019).”
Tom, V. V., Dixit, S. R., Pujar, K. G., Sasidharan, A., Deepthi, K., Zakiya Fathima, C., Somayaji, Y., & Fernandes, R. (2025) · Neurotoxicity Research · doi:10.1007/s12640-025-00766-y · Cited by 2
“…promotion of a pro-inflammatory M1 microglial phenotype, and subsequent neuronal dysfunction, all hallmarks of chronic neuroinflammation in neurodegenerative disease all of which are implicated in behavioral changes, glial activation, and neuronal damage (Ding et al. 2022; Piancone et al. 2021).”
Mitochondrial Transplantation Therapy for Ischemic Stroke: Progress and Challenges
Zhao, Z.-H., Yang, X.-L., Lu, Z., Li, T., Zhao, L.-L., Li, Y., Dang, M., Zhang, G.-L., Chen, K., & Fan, H. (2026) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-026-01682-1 · Cited by 5
“…evidence indicates that ischemic stroke triggers diverse mechanisms of cell death, such as apoptosis, ferroptosis, pyroptosis, necroptosis, parthanatos and autophagy (Yan et al. 2021; Butler et al. 2021; Candelario-Jalil et al. 2022; Wang et al. 2019; Piancone et al. 2021; Koehler et al. 2021).”
Imaging Inflammasome Activation in Microglia
Martin, N. P., & Harry, G. J. (2022) · Current Protocols · doi:10.1002/cpz1.578 · Cited by 4
Kadiyska, T., Tourtourikov, I., Madzharova, D., Ciurinskiene, S., Savcheva, M., Ivanova‐Todorova, E., Mileva-Popova, R., Tafradjiiska-Hadjiolova, R. K., & Mitev, V. (2025) · Journal of Molecular Neuroscience · doi:10.1007/s12031-025-02399-4 · Cited by 3
“…of these factors appear to be shared by other neurodegenerative disorders due to shared upregulation in neuroinflammation, increased microglia activation, and/or abnormalities in language processing related to frontal/basal ganglia circuit dysfunction (Nardone et al. 2014; Piancone et al. 2021).”
Kumar, P. P., Darshini, I. S., & Prashanth, K. V. H. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-19084-1.00026-0 · Cited by 3
Prevention of Dementia with ω3 Fatty Acids-Up to Date
Hashimoto, M., & Gamoh, S. (2022) · Oleoscience · doi:10.5650/oleoscience.22.327 · Cited by 1
Muscle fatigue and exercise-related biomarkers in amyotrophic lateral sclerosis
Bianchi, F., Becattini, L., Chico, L., Ricci, G., & Siciliano, G. (2023) · Exploration of Neuroprotective Therapy · doi:10.37349/ent.2023.00045 · Cited by 1
Expression pattern of long non-coding RNAs in treatment-naïve and medicated schizophrenia patients
Javidi-Aghdam, K., Baradaran, B., Rahmani, S., Manafzadeh, F., Azar, S. G. N., Aghayan, S. S., Shayannia, A., & Ghafouri‐Fard, S. (2024) · Scientific Reports · doi:10.1038/s41598-024-78220-w · Cited by 1
Yang, E. J. (2025) · Pharmacology · doi:10.1159/000547388 · Cited by 1
“Inflammation triggered by excessive oxidative stress can significantly impact neurodegenerative disorders, such as Alzheimer’s disease, Parkinson’s disease, and ALS [2].”
Zeng, W., Lei, X., Liu, H., Zheng, S., Wang, Q., & Niu, X. (2025) · Translational Neuroscience · doi:10.1515/tnsci-2025-0370 · Cited by 2
IL-18 binding protein attenuates neuroinflammation and cognitive decline in Alzheimer’s disease
Hong, D. K., Jeon, S. H., Kang, M., Lee, S., Liu, X., Ahn, E. H., & Kang, S. (2026) · Journal of Neuroinflammation · doi:10.1186/s12974-026-03720-7 · Cited by 2
“In the brain, IL-18 is produced primarily by microglia, the resident immune cells, in response to inflammatory signals, particularly those mediated by the NOD-like receptor protein 3 (NLRP3) inflammasome [17, 18].”
Chi, L., Tu, H., Li, Z., Qiu, L., Zhang, Z., Chia, S., Tan, J. Y., Ho, I. A. W., Loh, Y., Tan, E., et al. (2026) · Cell Death Discovery · doi:10.1038/s41420-026-02995-2 · Cited by 3
TREM2 restrains myeloid inflammasome activation to protect against photoreceptor degeneration
wang, T., Su, L., Szczepan, M., Wang, X., Gregg, A. T., Guo, J., Smith, L. E. H., & Sun, Y. (2026) · Journal of Neuroinflammation · doi:10.1186/s12974-026-03903-2 · Cited by 1
“In contrast, dysregulated IFN signaling and inflammasome activation drive myeloid pathology [31, 32].”
IL-1 polymorphisms modulates functional recovery following rehabilitation in multiple sclerosis
Agliardi, C., Guerini, F. R., Zanzottera, M., Bolognesi, E., Caputo, D., Groppo, E., Rovaris, M., & Clerici, M. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1872267 · Cited by 1
Self-citationThe autophagy-senescence-inflammasome axis: A novel triad in neurodegenerative diseases?
Ellappan, S., Kujur, P. P., & Mondal, A. C. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103248 · Cited by 1
Transition of Microglia to Reactive States
Walz, W. (2023) · Springer eBooks · doi:10.1007/978-3-031-48105-5_5 · Cited by 1
Cytokines in Neurodegenerative Disorders
Pahan, K. (2024) · Springer eBooks · doi:10.1007/978-3-031-68237-7_12 · Cited by 1
Zeng, T., Zhang, C., Sun, L., & Xu, H. (2025) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-024-01660-8 · Cited by 2
Shafi, V. (2024) · Research Square · doi:10.21203/rs.3.rs-4232044/v1 · Cited by 1
Retinal microglial cells increase expression and release of IL-1β when exposed to ATPPreprint
Campagno, K. E., Lu, W., Sripinun, P., Albalawi, F., Cenaj, A., & Mitchell, C. H. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.06.25.600617 · Cited by 1
Sancho, M., Soriano‐Teruel, P. M., & Orzáez, M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91802-2.00038-4
de la Salud, F. U. D. C., Cuenca, N. T. R., Lamas, D. P., Scientific, P. P. O. T., Hawa, R. F., Clínica Unión Médica del Norte, P. U. C. M. Y. M., Quezada, K., Health, T. O. I., García, L., Marroquín, U. F., et al. (2023) · Principles and Practice of Clinical Research Journal · doi:10.21801/ppcrj.2023.92.7
Serrano‐Dueñas, M. (2023) · Depósito Académico Digital Universidad de Navarra (University of Navarra) · doi:10.15581/10171/68415
Fan, L., Yang, J., Liu, R.-Y., Kong, Y., Guo, G., & Xu, Y. (2023) · Figshare · doi:10.6084/m9.figshare.24180816
Fan, L., Yang, J., Liu, R.-Y., Kong, Y., Guo, G., & Xu, Y. (2023) · Figshare · doi:10.6084/m9.figshare.24180807
Fan, L., Yang, J., Liu, R.-Y., Kong, Y., Guo, G., & Xu, Y. (2023) · Figshare · doi:10.6084/m9.figshare.24180792
Fan, L., Yang, J., Liu, R.-Y., Kong, Y., Guo, G., & Xu, Y. (2023) · Figshare · doi:10.6084/m9.figshare.24180789
Fan, L., Yang, J., Liu, R.-Y., Kong, Y., Guo, G., & Xu, Y. (2023) · Figshare · doi:10.6084/m9.figshare.24180810
Fan, L., Yang, J., Liu, R.-Y., Kong, Y., Guo, G., & Xu, Y. (2023) · Figshare · doi:10.6084/m9.figshare.24180795
Fan, L., Yang, J., Liu, R.-Y., Kong, Y., Guo, G., & Xu, Y. (2023) · Figshare · doi:10.6084/m9.figshare.24180786
Fan, L., Yang, J., Liu, R.-Y., Kong, Y., Guo, G., & Xu, Y. (2023) · Figshare · doi:10.6084/m9.figshare.24180813
Fan, L., Yang, J., Liu, R.-Y., Kong, Y., Guo, G., & Xu, Y. (2023) · Figshare · doi:10.6084/m9.figshare.24180801
Fan, L., Yang, J., Liu, R.-Y., Kong, Y., Guo, G., & Xu, Y. (2023) · Figshare · doi:10.6084/m9.figshare.24180798
Akhmadieva, L. A., Nagiev, K. K., Zefirov, A. L., & Mukhamedyarov, M. A. (2024) · Kazan medical journal · doi:10.17816/kmj567814
Regulated cell death: Discovery, features, and implications for neurodegenerative diseases
Pandey, S. K., Nanda, A., Singh, S., & Singh, R. K. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-32852-7.00001-2
Autophagy and Neuroinflammatory Pathways in Alzheimer’s Disease
Gupta, R. V., Pawar, J. S., Gujjari, L., & Kumari, S. (2025) · Springer eBooks · doi:10.1007/978-981-95-3945-1_8
Neuronal loss and synaptic dysfunction
Pandya, K., Tripathi, P. N., & Kumar, D. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-36295-8.00016-x
Fan, L.-Y., Yang, J., Liu, R.-Y., Kong, Y., Guo, G., & Xu, Y.-M. (2023) · Figshare · doi:10.6084/m9.figshare.24180783
Epithelial-dermal inflammasome crosstalk in cutaneous squamous cell carcinoma
Wang, R., Patel, K. R., Shu, R. R., Tekale, K., Hamersky, M., Perez, A. B., Solano, D., Syed, N., Stewart, C. E., Lee, J., et al. (2026) · Molecular Biology of the Cell · doi:10.1091/mbc.e25-04-0181
“…studied in the context of myeloid-driven inflammatory processes, recent research has highlighted the potential role of this signaling in autoimmunity, metabolic and degenerative disease, and cancer (Hernandez et al., 2016; Piancone et al., 2021; Sharma and Kanneganti, 2021; Olsen et al., 2022).”
Liu, J., Zhou, L., Deng, Y., & Xu, R. (2026) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-25-00221 · Cited by 2
Eciroglu, H., Yıldız, F., Koçancı, F. G., Çelik, P. A., & Derya-Andeden, M. (2026) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.70774 · Cited by 1
“However, it remains unclear whether neuroinflammation is a primary causal factor or a secondary consequence of neurodegenerative pathology [4, 5].”
Firdoos, S., Dai, R., Shah, F. A., & Younas, Z. (2026) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.70120
Irisin hampers β-amyloid-induced microglial inflammation via the miR-451a/TLR4/NLRP3 axis
Mancuso, R., Saresella, M., Nuzzi, R., Agostini, S., Marventano, I., Hernis, A., Rosa, F. L., Piancone, F., & Clerici, M. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1761520 · Cited by 1
Self-citationHegedus, E., Nagybányai-Nagy, B., Neuperger, P., Balogh, F., Kari, B., Szebeni, G., Molnár, T., & Csécsei, P. (2026) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2026.112165
Fadhil, S. A., Gholami, A. A., Rustamov, F., Axmedova, M., Aliev, S., & Oqboyev, Z. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-12353-1
“Given that sustained inflammasome activation drives IL-1β-mediated synaptic dysfunction, targeted modulation of the NF-κB/NLRP3 axis represents a rational therapeutic strategy [22, 23, 25].”
LINE-1 Retrotransposons and Amyotrophic Lateral Sclerosis
Korošec, T., Rogelj, B., & Župunski, V. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27146244
Chandgude, A. L., Loriga, G., Beccu, A., Iannotti, F. A., Pagano, E., Capasso, R., Fusco, R., Spanu, P., Ulgheri, F., & Dömling, P. D. A. (2026) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2026.118794
Suvashini, S., Harshitha, P., Parithathvi, A., & Dsouza, H. S. (2026) · Biological Trace Element Research · doi:10.1007/s12011-026-05320-1
Metadata
- Authors
- Piancone, F., La Rosa, F., Marventano, I., Saresella, M., & Clerici, M.
- Affiliations
- Don Carlo Gnocchi Foundation (IT)
- IRCCS Fondazione Don Carlo Gnocchi, 20148 Milano, Italy
- University of Milan (IT)
- Corresponding author
- Piancone, Federica
- Venue
- Molecules
- Publisher
- MDPI AG
- Published
- 2021-02-11
- Volume
- 26
- Issue
- 4
- Pages
- 953
- ISSN
- 1420-3049 (ISSN-L)
- PMC
- PMC7916884
- OpenAlex
- W3128695211
- Cited by
- 144
- References
- 99
- Citations by year
- 2026: 18 · 2025: 30 · 2024: 29 · 2023: 27 · 2022: 28 · 2021: 12
- FWCI
- 2.78
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Molecules (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Keywords
- inflammasome, neurodegenerative diseases, neuroinflammation, NLRP3 inflammasome, IL-1β, IL-18, caspase-1, NOD-like receptors, microglia, monocytes, Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, multiple sclerosis, inflammasome inhibitors, neuroinflammation therapy
- MeSH terms
- NLR Family, Pyrin Domain-Containing 3 Protein, Alzheimer Disease, Amyotrophic Lateral Sclerosis, Humans, Multiple Sclerosis, Parkinson Disease, Signal Transduction, Neurodegenerative Diseases, Interleukin-18, Interleukin-1beta, Inflammasomes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.